The flip-flop between radioiodine scan and FDG-PET has been a recognized fact in the parlance of DTC and nuclear medicine imaging procedures are being utilized to explore the various aspects of thyroid cancer including tumor biology and heterogeneity of tumor characteristics. [1] [2] [3] [4] The interesting aspect of this case is the visual demonstration of both well-differentiated asymptomatic metastases and a focus of aggressive poorly differentiated tumor in the same patient. While, this process is most likely present to some extent in practice in a number of patients whose tumors eventually transform into poorly differentiated lesions, the peer reviewed literature at present, primarily describes studies that addresses FDG-PET positive versus 131I positive tumors and tend to describe patients as falling into either of these two imaging categories. There is relatively little information on patients who concurrently manifest both 131I and PET positive lesions. Thus, such presentations and clinical discourse would be more scientifically useful to develop this concept which would hopefully impact the management approach in this group of patients in the future. The finding illustrated would thus call more attention to the fact that clinicians should be aware that varying tumor biology amongst the metastatic lesions can be encountered in the same patient of DTC and neither imaging modality is completely accurate, and that concerning symptoms in an individual patient would warrant further evaluation. The aggressive nature of FDG positive lesions and the associated relatively poor survival with PET positive disease is well recognized in practice. Additionally, the case demonstrates an example of cutaneous metastases from DTC, a relatively uncommon site of disease spread in the setting of well-differentiated thyroid cancer, of which the scalp being the most commonly reported site of skin involvement.
